|
1
|
Ragin CC, Modugno F and Gollin SM: The
epidemiology and risk factors of head and neck cancer: A focus on
human papillomavirus. J Dent Res. 86:104–114. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Ward E, Murray T, Xu J
and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 57:43–66.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Knab BR, Salama JK, Solanki A, Stenson KM,
Cohen EE, Witt ME, Haraf DJ and Vokes EE: Functional organ
preservation with definitive chemoradiotherapy for T4 laryngeal
squamous cell carcinoma. Ann Oncol. 19:1650–1654. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Du LB, Mao WM, Chen WQ, Zhang SW, Yu CD,
Zheng RS, Xia QM and Wang XH: Incidence and mortality of larynx
cancer in China during 2003–2007. Zhonghua Liu Xing Bing Xue Za
Zhi. 33:395–398, (In Chinese). PubMed/NCBI
|
|
5
|
Cripps C, Winquist E, Devries MC,
StysNorman D and Gilbert R: Head and Neck Cancer Disease Site
Group: Epidermal growth factor receptor targeted therapy in stages
III and IV head and neck cancer. Curr Oncol. 17:37–48. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ji W, Guan C and Pan Z: Analysis of
curative effects on laryngeal carcinoma patients in the northeast
region of China. Acta Otolaryngol. 128:574–577. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ozdek A, Sarac S, Akyol MU, Sungur A and
Yilmaz T: c-myc and bcl-2 Expression in supraglottic squamous cell
carcinoma of the larynx. Otolaryngol Head Neck Surg. 131:77–83.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jain P, Kumar P, Pai VR and Parikh PM:
Neoadjuvant chemotherapy or chemoradiotherapy in head and neck
cancer. Indian J Cancer. 45:83–89. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bieller A, Pasche B, Frank S, Gläser B,
Kunz J, Witt K and Zoll B: Isolation and characterization of the
human forkhead gene FOXQ1. DNA Cell Biol. 20:555–561. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Feuerborn A, Srivastava PK, Küffer S,
Grandy WA, Sijmonsma TP, Gretz N, Brors B and Gröne HJ: The
Forkhead factor FoxQ1 influences epithelial differentiation. J Cell
Physiol. 226:710–719. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Korver W, Roose J and Clevers H: The
winged-helix transcription factor Trident is expressed in cycling
cells. Nucleic Acids Res. 25:1715–1719. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ogaki S, Harada S, Shiraki N, Kume K and
Kume S: An expression profile analysis of ES cell-derived
definitive endodermal cells and Pdx1-expressing cells. BMC Dev
Biol. 11:132011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Carlsson P and Mahlapuu M: Forkhead
transcription factors: Key players in development and metabolism.
Dev Biol. 250:1–23. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Candelario J, Chen LY, Marjoram P, Reddy S
and Comai L: A filtering strategy identifies FOXQ1 as a potential
effector of lamin A dysfunction. Aging (Albany NY). 4:567–577.
2012.PubMed/NCBI
|
|
15
|
Sizemore ST and Keri RA: The forkhead box
transcription factor FOXC1 promotes breast cancer invasion by
inducing matrix metalloprotease 7 (MMP7) expression. J Biol Chem.
287:24631–24640. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wendling DS, Lück C, von Schweinitz D and
Kappler R: Characteristic overexpression of the forkhead box
transcription factor Foxf1 in Patched-associated tumors. Int J Mol
Med. 22:787–792. 2008.PubMed/NCBI
|
|
17
|
Xia L, Huang W, Tian D, Zhu H, Qi X, Chen
Z, Zhang Y, Hu H, Fan D, Nie Y, et al: Overexpression of forkhead
box C1 promotes tumor metastasis and indicates poor prognosis in
hepatocellular carcinoma. Hepatology. 57:610–624. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jonsson H and Peng SL: Forkhead
transcription factors in immunology. Cell Mol Life Sci. 62:397–409.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kaneda H, Arao T, Tanaka K, Tamura D,
Aomatsu K, Kudo K, Sakai K, De Velasco MA, Matsumoto K, Fujita Y,
et al: FOXQ1 is overexpressed in colorectal cancer and enhances
tumorigenicity and tumor growth. Cancer Res. 70:2053–2063. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Feng J, Zhang X, Zhu H, Wang X, Ni S and
Huang J: FoxQ1 overexpression influences poor prognosis in
non-small cell lung cancer, associates with the phenomenon of EMT.
PLoS One. 7:e399372012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang H, Meng F, Liu G, Zhang B, Zhu J, Wu
F, Ethier SP, Miller F and Wu G: Forkhead transcription factor
foxq1 promotes epithelial-mesenchymal transition and breast cancer
metastasis. Cancer Res. 71:1292–1301. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sobin LH and Wittekind C: Head and neck
tumors, larynxTNM Classification of Malignant Tumors. 6th.
Wiley-Liss; New York, NY: pp. 52–56. 2002
|
|
23
|
Potter CS, Peterson RL, Barth JL, Pruett
ND, Jacobs DF, Kern MJ, Argraves WS, Sundberg JP and Awgulewitsch
A: Evidence that the satin hair mutant gene Foxq1 is among multiple
and functionally diverse regulatory targets for Hoxc13 during hair
follicle differentiation. J Biol Chem. 281:29245–29255. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hong HK, Noveroske JK, Headon DJ, Liu T,
Sy MS, Justice MJ and Chakravarti A: The winged helix/forkhead
transcription factor Foxq1 regulates differentiation of hair in
satin mice. Genesis. 29:163–171. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun HT, Cheng SX, Tu Y, Li XH and Zhang S:
FoxQ1 promotes glioma cells proliferation and migration by
regulating NRXN3 expression. PLoS One. 8:e556932013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qiao Y, Jiang X, Lee ST, Karuturi RK, Hooi
SC and Yu Q: FOXQ1 regulates epithelial-mesenchymal transition in
human cancers. Cancer Res. 71:3076–3086. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gao M, Shih IeM and Wang TL: The role of
forkhead box Q1 transcription factor in ovarian epithelial
carcinomas. Int J Mol Sci. 13:13881–13893. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qin J, Xu Y, Li X, Wu Y, Zhou J, Wang G
and Chen L: Effects of lentiviral-mediated Foxp1 and Foxq1 RNAi on
the hepatocarcinoma cell. Exp Mol Pathol. 96:1–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Piccolo S, Enzo E and Montagner M: p63,
Sharp1, and HIFs: Master regulators of metastasis in
triple-negative breast cancer. Cancer Res. 73:4978–4981. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Agarwal E, Brattain MG and Chowdhury S:
Cell survival and metastasis regulation by Akt signaling in
colorectal cancer. Cell Signal. 25:1711–1719. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhu Z, Pang Z, Xing Y, Wan F, Lan D and
Wang H: Short hairpin RNA targeting FOXQ1 inhibits invasion and
metastasis via the reversal of epithelial-mesenchymal transition in
bladder cancer. Int J Oncol. 42:1271–1278. 2013.PubMed/NCBI
|
